IMUX · XBRL financial data

Immunic financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (IMUX's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023†Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Research and development	38,637	61,115	71,255	83,215	80,046	81,983
General and administrative	10,334	13,300	15,263	16,008	18,006	21,245
Total operating expenses	48,971	91,665	119,488	99,223	98,052	103,228
Operating income (loss)	(48,971)	(91,665)	(119,488)	(99,223)	(98,052)	(103,228)
Interest income	58	66	1,041	3,075	3,390	1,040
Other income (expense)	4,896	(1,346)	(1,960)	2,536	(1,049)	5,016
Income tax expense (benefit)	—	—	—	—	—	0
Net income (loss)	(44,017)	(92,945)	(120,407)	(93,612)	(100,507)	(97,172)
Earnings per share, basic USD per share	(2.81)	(3.93)	(3.78)	(2.11)	(1.00)	(0.62)
Earnings per share, diluted USD per share	(2.81)	(3.93)	(3.78)	(2.11)	(1.00)	(0.62)
Weighted average shares, basic thousands of shares	15,664	23,653	31,819	44,320	100,175	155,688
Weighted average shares, diluted thousands of shares	15,664	23,653	31,819	44,320	100,175	155,688

† Share count changed about 2x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal years (IMUX's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023†Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	127,452	86,863	106,745	46,674	35,668	15,483
Prepaid and other current assets	6,293	18,125	9,490	5,860	3,664	7,386
Total current assets	133,745	104,988	125,864	52,534	39,332	22,869
Property and equipment, net	203	152	294	466	545	608
Right-of-use asset	901	948	1,552	1,299	991	575
Goodwill	32,970	32,970	0	—	—	—
Total assets	167,861	139,100	127,753	54,299	40,868	24,052
Accounts payable	3,700	3,745	4,281	5,099	7,846	10,138
Accrued liabilities	4,318	7,071	7,986	18,664	12,913	18,645
Total current liabilities	8,397	11,401	13,077	24,729	22,175	30,618
Lease liability, non-current	679	584	992	639	264	107
Total liabilities	9,076	11,985	14,069	25,368	22,439	30,725
Accumulated deficit	(103,928)	(196,873)	(317,280)	(410,892)	(511,399)	(608,571)
Total stockholders' equity	158,785	127,115	113,684	28,931	18,429	(6,673)
Total liabilities and equity	167,861	139,100	127,753	54,299	40,868	24,052
Common shares outstanding (cover page) thousands of shares	21,168	27,907	44,404	89,929	90,151	130,465

† Share count changed about 2x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal years (IMUX's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023†Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(44,017)	(92,945)	(120,407)	(93,612)	(100,507)	(97,172)
Stock-based compensation	2,747	5,949	7,929	7,102	8,527	8,863
Depreciation and amortization	39	85	77	111	134	168
Net cash from operating activities	(46,124)	(83,233)	(65,144)	(70,828)	(84,766)	(85,806)
Purchases of property and equipment	146	67	112	334	264	161
Net cash from investing activities	(146)	(67)	(9,741)	9,462	(264)	(161)
Proceeds from issuing common stock	—	—	—	853	191	0
Net cash from financing activities	144,431	42,841	95,760	1,033	74,541	65,577
Net change in cash	98,083	(40,589)	19,882	(60,071)	(11,006)	(20,185)

† Share count changed about 2x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

The peer list for this company is being put together from its industry's latest filings. Reload the page in a minute to see it.

Not investment advice. Not affiliated with the U.S. SEC.